Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e35a35338731a170f873b55f8cd5b348 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e82d4520ba52582113786f12ecab3a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9f8f7395aa059c69d00a60516c4c9b4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
filingDate |
2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0dcef70d288abd4917db7c577b76e2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f662477eac908f84cb6511786f89442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccbeb65c32a5a4054ffaffdb2104697a |
publicationDate |
2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004047736-A2 |
titleOfInvention |
Modulation of bcl2-associated athanogene expression |
abstract |
Compounds, compositions and methods are provided for modulating the expression of BCL2-associated athanogene. The compositions comprise oligonucleotides, targeted to nucleic acid encoding BCL2-associated athanogene. Methods of using these compounds for modulation of BCL2-associated athanogene expression and for diagnosis and treatment of disease associated with expression of BCL2-associated athanogene are provided. |
priorityDate |
2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |